Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $136 from $127 and keeps an Overweight rating on the shares. Diversified Managed Care “woefully underperformed” in 2024 and while uncertainty is pressuring sentiment, the firm sees “opportunities in a friendlier policy backdrop,” the analyst tells investors in a 2025 outlook note on the healthcare services group. Drug distributors “have rightfully been viewed as relative safe havens” and the firm thinks stocks in the group can continue to “grind higher,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Salesforce upgraded, ServiceNow downgraded: Wall Street’s top analyst calls
- Wells upgrades Cardinal Health to Equal Weight with thesis played out
- Cardinal Health upgraded to Equal Weight from Underweight at Wells Fargo
- Cardinal Health awarded $9B Defense Logistics Agency contract modification
- Cardinal Health assumed with an Outperform at Mizuho